To ask the Secretary of State for Health and Social Care, when the next planned review date is for the assessment and management of motor neurone disease.
The National Institute for Health and Care Excellence (NICE) has advised that the guideline on ‘Motor Neurone Disease: assessment and management’ is currently not scheduled for review. NICE has processes in place to periodically review its guidelines to ensure that they reflect the latest available evidence. Such reviews are normally carried out every five years. As the guideline was published in 2016, the latest the surveillance review would be undertaken will be 2020/21.
If significant new evidence that is likely to affect the guideline’s recommendations emerges before then, NICE is able to bring forward the surveillance review.